Search anything
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
SPARC shares hit upper circuit after a US district court backed its case on Sezaby’s priority review voucher, giving the FDA 60 days to appeal the decision.
Netweb Technologies shares rallied about 19% in two sessions after unveiling Nvidia-powered, Make in India AI supercomputing systems, lifting sentiment around domestic AI infrastructure plays.
Mankind Pharma’s next results are due on 19 May 2026, following Q3 FY25-26 performance with ₹2,632.68 crore sales and ₹449.47 crore profit.
Zydus Lifesciences reported higher Q3 FY26 adjusted profit and a sharp revenue rise, led by India and North America growth, improving margins, and a stronger chronic mix.
RBI has proposed a revised Basel III Pillar 3 framework that mandates uniform quarterly disclosures on capital, leverage, liquidity and risk, with final rules planned from September 2026 quarter.
Power Grid’s multi-year order visibility and rising capex guidance underline steady, regulated earnings prospects, even as execution pace and grid integration needs remain key monitorables.
Mankind Pharma reported 27.1% YoY revenue growth in Q4 FY25 led by chronic, exports and BSV consolidation, while profit fell amid integration costs and acute regulatory issues.
Indian equities stayed volatile as Middle East tensions, crude swings, a weak rupee and FII selling hit benchmarks, while smallcaps outperformed and banking stocks saw sharp reversals.
Hindalco’s wholly owned unit Novelis posted a Q4FY26 net loss of $84m despite higher sales, as Oswego plant fires cut shipments and raised fire-related costs.
Sebi and NSE leaders say domestic investors, broader participation and reforms are cushioning Indian markets despite West Asia-driven volatility, crude spikes and foreign portfolio outflows.
Omaxe will invest ₹1,200 crore to develop a 450-acre integrated township on Indore’s Super Corridor, targeting ₹2,500 crore revenue in three years, funded via internal accruals.
Indian stocks recovered sharply on IT and pharma strength even as the rupee hit a record low near 96.3 per dollar, pressured by higher crude and global yields.
Exicom reported FY26 consolidated revenue of ₹1,152 crore and a Q4 EBITDA breakeven, supported by higher standalone margins, export growth, and Tritium’s commercial ramp-up.
Jindal (India) said it completed a ₹1,500-crore West Bengal capex with a new Howrah colour coating line, lifting capacity to 60,000 tonnes a month and guiding higher revenue.
Morningstar reported $4.97 billion net outflows from India-focused offshore funds and ETFs in Jan–Mar 2026 as geopolitics, valuations and higher yields pushed investors to safer assets.
RBI has cancelled The Yashwant Co-operative Bank’s licence in Phaltan, asking Maharashtra authorities to wind it up, while DICGC insurance covers deposits up to ₹5 lakh.
